A ketogenic diet is high fat, moderate protein and very low carbohydrate, shifting metabolism toward ketones. It is proven in drug-resistant pediatric epilepsy, where 50-70% of children achieve major seizure reduction, and a one-year study reported diabetes reversal in 60% of patients. Evidence for Alzheimer's, psychiatric conditions, cancer adjunct use and longevity is early and mostly mechanistic, which is why the overall rating stays cautious.
Summary drafted from this entry’s sources; editorial review pending.
01Key questions
Does the keto diet work for epilepsy?
Yes. Used since the 1920s for drug-resistant epilepsy, 50-70% of children achieve at least a 50% reduction in seizures.1
Does keto work for type 2 diabetes?
It lowers glucose and insulin quickly, and a one-year study reported 60% of patients achieving diabetes reversal on a sustained ketogenic care model. That was a single care-model study rather than a drug-style trial.3
Does keto help the brain?
Possibly. Ketones bypass impaired glucose metabolism, and early evidence exists for Alzheimer's, bipolar disorder and depression, but it is mostly pilots, case series and mechanism rather than large trials.34
Is keto safe long-term?
LDL cholesterol commonly rises and its significance is debated; kidney stones and nutrient gaps are manageable risks. Rare metabolic disorders such as carnitine deficiency are absolute contraindications.
What would change this rating?
Randomized trials in the neurological and psychiatric indications, and long-term cardiovascular outcome data.
Core thesis: The ketogenic diet — high fat, moderate protein, very low carbohydrate — shifts the body's primary fuel from glucose to ketones. Originally developed for pediatric epilepsy in the 1920s, it is now recognized as a powerful metabolic therapy with applications spanning neurology, psychiatry, oncology, metabolic disease, and performance optimization.
02The Science of Ketosis
What Is Nutritional Ketosis?
- Definition: Serum ketone levels 0.5-3.0 mmol/L (β-hydroxybutyrate)
- Not the same as ketoacidosis: Diabetic ketoacidosis involves ketones >20 mmol/L with uncontrolled blood glucose. Nutritional ketosis is a regulated, physiological state.
Ketone Bodies as Signaling Molecules
Ketones are not just fuel — they are potent signaling molecules: - β-hydroxybutyrate (BHB): Inhibits HDACs (epigenetic effects), activates Nrf2 (antioxidant), reduces NLRP3 inflammasome, increases BDNF - Superfuel: Ketones produce more ATP per unit oxygen than glucose - Neuroprotective: Bypass impaired glucose metabolism in neurodegeneration - Anti-inflammatory: Suppress NF-κB and NLRP3 pathways
Metabolic Switch
| Parameter | Glucose Metabolism | Ketone Metabolism |
|---|---|---|
| Primary hormone | Insulin | Glucagon + Adrenaline |
| Fuel storage | Glycogen (limited) | Body fat (extensive) |
| Insulin level | High | Low |
| Inflammation | Higher | Lower |
| Oxidative stress | Higher (ROS) | Lower (mitochondrial efficiency) |
| Brain fuel | Glucose | Ketones (70%) + glucose (30%) |
Swipe table →
03Variants of Ketogenic Diets
Standard Ketogenic Diet (SKD)
- Macros: 70-80% fat, 15-20% protein, 5-10% carbohydrate
- Classic therapeutic ketogenic diet
Modified Ketogenic Diet
- Macros: 60-65% fat, 20-25% protein, 10-15% carbohydrate
- More sustainable for long-term adherence
Targeted Ketogenic Diet (TKD)
- Standard keto + 15-30g fast-digesting carbs around training
- For athletes needing glucose for high-intensity work
Cyclical Ketogenic Diet (CKD)
- 5-6 days keto + 1-2 days higher carb
- Popular among bodybuilders
- Can disrupt metabolic adaptation if not done carefully
High-Protein Ketogenic
- 60% fat, 30% protein, 10% carbs
- Better for maintaining lean mass during weight loss
- May not produce deep ketosis in all individuals
04Evidence by Condition
Epilepsy (Strongest Evidence)
- Since 1921: Mayo Clinic developed keto diet for drug-resistant epilepsy
- 50-70% of children with drug-resistant seizures achieve >50% reduction (PMID 22470316)
- Mechanism: enhanced GABAergic inhibition, reduced neuronal excitability, ketone-mediated neuroprotection
- Now being reconsidered for adult epilepsy
Metabolic Syndrome & Type 2 Diabetes (Strong)
- Rapidly reduces fasting glucose and insulin levels
- Improves HbA1c — some studies show superiority to standard dietary approaches
- Reduces hepatic steatosis (fatty liver)
- Hallberg et al. (2018): 60% of T2D patients achieved reversal at 1 year on sustained keto (PMID 29478799)
Neurological/Psychiatric Conditions (Growing)
- Alzheimer's disease: Brain insulin resistance ("Type 3 diabetes") — ketones bypass impaired glucose metabolism (PMID 9728807)
- Parkinson's disease: Early evidence of symptom improvement
- Bipolar disorder/Depression: Ketogenic Metabolic Therapy (KMT) — case series and pilot studies show improvements (PMID 30075165, 39234289)
- Schizophrenia: Emerging case reports and theoretical framework (PMID 40365237)
- Traumatic brain injury: Ketone neuroprotection after TBI
Cancer (Contested/Emerging)
- Warburg effect: Many cancers are obligate glucose consumers — ketosis may selectively stress cancer cells
- Adjunct to therapy: Fasting/keto may enhance chemo and radiation efficacy ("differential stress resistance")
- Not a standalone cancer treatment — but promising as metabolic adjunct
- Dom D'Agostino's research at USF on hyperbaric oxygen + ketosis for cancer
Weight Loss (Strong)
- Consistently outperforms low-fat diets in short-medium term
- Spontaneous caloric reduction due to appetite suppression from ketones + protein
- Greater preservation of lean mass than calorie-restricted diets
PCOS (Moderate)
- Improves insulin sensitivity (core driver of PCOS)
- Reduces androgen levels
- Improves menstrual regularity
05Monitoring Ketosis
| Method | What It Measures | Target Range | Pros/Cons |
|---|---|---|---|
| Blood ketone meter | β-hydroxybutyrate | 0.5-3.0 mmol/L | Gold standard, most accurate |
| Urine strips | Acetoacetate | Color change | Cheap, only useful in first 2 weeks |
| Breath meter | Acetone | Correlates with BHB | Non-invasive, moderate accuracy |
| Symptoms | Energy, mental clarity, appetite | Subjective | Useful personal biomarker |
Swipe table →
06Practical Context
Getting Into Ketosis (1-7 days)
- Increase fat to compensate (don't calorie restrict initially)
- Moderate protein (0.8-1.5g/kg body weight)
- Hydrate aggressively + supplement electrolytes
- Expect adaptation symptoms (fatigue, brain fog, headaches)
Keto-Adaptation (3-8 weeks)
- Mitochondria upregulate ketone utilization enzymes
- Exercise capacity initially reduced, then rebounds
- Mental clarity and energy typically improve significantly
- "Fat-adapted" = body efficiently burns fat for fuel
Common Mistakes
- Too much protein (unlikely to kick most people out, but possible)
- Not enough electrolytes (sodium, potassium, magnesium critical)
- Hidden carbs (sauces, vegetables, "keto" products)
- Fear of fat (must replace carb calories with fat)
- Impatience during adaptation
07Safety & Contraindications
| Concern | Assessment |
|---|---|
| Keto flu | Temporary electrolyte imbalance during adaptation — preventable |
| LDL elevation | Common; significance debated. Monitor ApoB, Lp(a), coronary calcium score |
| Kidney stones | Slightly increased risk — maintain hydration, consider potassium citrate |
| Nutrient deficiency | Possible without planning — organ meats, diverse protein sources help |
| Athletic performance | Impaired anaerobic performance initially; endurance may improve long-term |
Swipe table →
Absolute contraindications: Rare metabolic disorders (carnitine deficiency, MCAD deficiency, porphyria)
Further reading: detailed protocols
- Charlie Foundation: ketogenic therapy guides charliefoundation.org
08Connections
09Sources
- PubMed 22470316PubMed 22470316
- PubMed 29478799PubMed 29478799
- Włodarek D. (2019). "Role of Ketogenic Diets in Neurodegenerative Diseases." Nutrients . PMID 9728807PubMed 9728807
- PubMed 30075165PubMed 30075165
- PubMed 40365237PubMed 40365237
- Paoli A et al. (2013). "Beyond Weight Loss: A Review of the Therapeutic Uses of Very-Low-Carbohydrate (Ketogenic) Diets." Eur J Clin Nutr . PMID 23801097PubMed 23801097
- Sethi S et al. (2024). "Ketogenic Metabolic Therapy for Mental Health." PMID 39234289PubMed 39234289
- Newman JC, Verdin E. (2014). "β-Hydroxybutyrate: A Signaling Metabolite." Cell Metabolism . PMID 25440058PubMed 25440058
10Entry history
Latest content update.
Heretic informs and never prescribes. Where amounts appear, they describe what published studies used. Talk to a qualified clinician before acting on anything here.